Cambridge, MA, United States of America

Mathieu E Nonnenmacher

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 68(Granted Patents)


Location History:

  • Cambridge, MA (US) (2020 - 2023)
  • Boston, MA (US) (2020 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mathieu E. Nonnenmacher

Introduction: Mathieu E. Nonnenmacher, an accomplished inventor based in Cambridge, MA, has made significant strides in the field of biotechnology. With a total of 14 patents to his name, he is recognized for his innovations in the preparation and therapeutic use of adeno-associated virus (AAV) particles. His work has potential implications for the prevention and treatment of various diseases, showcasing the impact of his contributions to medical science.

Latest Patents: Among his latest patents is a groundbreaking invention titled "Compositions and Methods for Delivery of AAV." This invention focuses on the preparation, manufacture, formulation, and therapeutic use of AAV particles aimed at combating diseases. Another significant patent, "AAV Capsid Variants and Uses Thereof," details compositions and methods for the preparation, use, and formulation of AAV capsid protein variants, further expanding therapeutic possibilities in gene therapy.

Career Highlights: Mathieu currently works at Voyager Therapeutics, Inc., a biotechnology company that specializes in gene therapy solutions. His role within the company has allowed him to leverage his expertise in developing AAV-based therapeutics. His innovative spirit and drive for excellence have made him a prominent figure in the biotech community, earning him respect and recognition.

Collaborations: Throughout his career, Mathieu has collaborated with notable professionals in the field, including Jinzhao Hou and Dinah Wen-Yee Sah. These partnerships reflect the collaborative nature of the biotechnology industry, emphasizing the importance of teamwork in driving innovation and achieving breakthroughs.

Conclusion: Mathieu E. Nonnenmacher exemplifies the role of inventors in advancing scientific knowledge and developing cutting-edge therapies. His patents not only reflect his ingenuity but also contribute to the potential modulation of treatment approaches for various diseases. As the field of biotechnology continues to evolve, innovators like Mathieu will undoubtedly play a critical role in shaping its future and enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…